5 Recruiting Chronic Myelomonocytic Leukemia Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for chronic myelomonocytic leukemia enrolling across the USA. Verify eligibility and contact site coordinators.
All Chronic Myelomonocytic Leukemia studiesPhase 1 / Phase 2 Studies for Chronic Myelomonocytic Leukemia
🔵 Active, Not Recruiting Phase1 / Phase2
Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Venetoclax in Combination With ASTX727 for the Treatment of Treatment-Naive High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed
📍 USC / Norris Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Pacritinib in CMML
📍 The Mount Sinai Hospital — New York, New York
View Study & Checklist ➔